Sale!

CRLF2 CML AML ALL Genetic Test

Original price was: $176.Current price is: $132.

-25%

The CRLF2 CML AML ALL Genetic Test is a specialized diagnostic examination that utilizes Fluorescence In Situ Hybridization (FISH) technology to detect specific genetic abnormalities associated with various forms of leukemia. This comprehensive test analyzes the CRLF2 gene rearrangement and other critical genetic markers in Chronic Myeloid Leukemia (CML), Acute Myeloid Leukemia (AML), and Acute Lymphoblastic Leukemia (ALL). By identifying precise genetic mutations, this test enables healthcare providers to develop targeted treatment strategies and monitor disease progression effectively. The test requires a bone marrow or peripheral blood sample and provides results within 3-4 days. Available at an affordable price of $132 USD, this advanced genetic screening offers crucial insights for leukemia diagnosis, prognosis assessment, and treatment response monitoring.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

CRLF2 CML AML ALL Genetic Test

Comprehensive Introduction to Leukemia Genetic Testing

The CRLF2 CML AML ALL Genetic Test represents a cutting-edge diagnostic approach in modern oncology, specifically designed to detect critical genetic abnormalities associated with various forms of leukemia. This advanced genetic screening utilizes Fluorescence In Situ Hybridization (FISH) technology to provide precise molecular insights that are essential for accurate diagnosis, prognosis assessment, and personalized treatment planning. The test’s importance lies in its ability to identify specific genetic rearrangements that drive leukemia development and progression, enabling healthcare providers to make informed clinical decisions and optimize patient outcomes.

What the Test Measures and Detects

This comprehensive genetic test specifically targets and analyzes:

  • CRLF2 Gene Rearrangements: Detects abnormalities in the cytokine receptor-like factor 2 gene, which plays a crucial role in leukemia development
  • CML-Specific Markers: Identifies genetic abnormalities characteristic of Chronic Myeloid Leukemia
  • AML Genetic Mutations: Screens for specific genetic changes associated with Acute Myeloid Leukemia
  • ALL Genetic Abnormalities: Detects genetic rearrangements relevant to Acute Lymphoblastic Leukemia
  • Chromosomal Translocations: Identifies specific chromosome rearrangements that drive leukemia progression

Who Should Consider This Test

This genetic test is particularly recommended for individuals experiencing:

  • Unexplained fatigue, weakness, or persistent tiredness
  • Frequent infections or unusual susceptibility to illnesses
  • Unexplained bruising, bleeding, or petechiae (small red spots)
  • Bone pain or tenderness in specific areas
  • Enlarged lymph nodes, spleen, or liver
  • Night sweats, fever, or unexplained weight loss
  • Abnormal blood cell counts detected in routine blood tests
  • Family history of hematological malignancies
  • Patients undergoing leukemia treatment to monitor response

Significant Benefits of Genetic Testing

Undergoing the CRLF2 CML AML ALL Genetic Test provides numerous advantages:

  • Accurate Diagnosis: Provides definitive genetic evidence for precise leukemia classification
  • Personalized Treatment: Enables targeted therapy selection based on specific genetic abnormalities
  • Prognostic Information: Offers insights into disease progression and potential outcomes
  • Treatment Monitoring: Allows tracking of treatment response and disease remission
  • Early Detection: Identifies genetic changes before clinical symptoms become severe
  • Family Risk Assessment: Provides information about potential hereditary factors

Understanding Your Test Results

Your genetic test results will provide critical information about:

  • Genetic Abnormalities: Presence or absence of specific CRLF2 rearrangements and other leukemia-associated mutations
  • Disease Classification: Specific type of leukemia based on genetic markers detected
  • Treatment Implications: Guidance on targeted therapies that may be most effective
  • Prognostic Indicators: Information about disease aggressiveness and potential outcomes
  • Monitoring Parameters: Baseline genetic markers for future treatment response assessment

It’s essential to discuss your results with a qualified hematologist or oncologist who can provide comprehensive interpretation and develop an appropriate treatment plan based on your specific genetic findings.

Test Pricing Information

Test Name Regular Price Discount Price
CRLF2 CML AML ALL Genetic Test $176 USD $132 USD

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee. Our extensive network ensures that advanced genetic testing is accessible to patients nationwide.

Schedule Your Genetic Test Today

Take the first step toward comprehensive leukemia diagnosis and personalized treatment planning. Our experienced genetic counselors and oncology specialists are ready to assist you with scheduling your CRLF2 CML AML ALL Genetic Test. Contact us today to book your appointment and receive the advanced genetic insights necessary for optimal leukemia management.

Call or WhatsApp: +1(267) 388-9828

Note: This test requires a doctor’s prescription for most cases. Prescription requirements may not apply for surgical planning, pregnancy-related testing, or international travel purposes. Please consult with our genetic counseling team for specific requirements.